Clinical Trials on Bone Diseases, Metabolic in New Zealand
Total 44342 results
-
Aligos TherapeuticsTerminatedChronic Hepatitis BUnited Kingdom, New Zealand
-
University of New MexicoWithdrawnHypovitaminosis DUnited States
-
State University of New York - Upstate Medical...CompletedRegional Osteoporosis as a Result of ChemotherapyUnited States
-
Yale UniversityNational Center for Advancing Translational Sciences (NCATS)SuspendedRickets | Hypophosphatemia | Hypercalciuria | XLH | HHRHUnited States
-
Roswell Park Cancer InstituteAmgenCompletedOsteoporosis | Osteopenia | Allogeneic Hematopoietic Stem Cell Transplantation RecipientUnited States
-
Far Eastern Memorial HospitalCompletedOsteoarthritis | OsteoporosisTaiwan
-
SanofiCompletedOsteochondrodysplasiaUnited States
-
Novartis PharmaceuticalsCompletedOsteoporosisUnited States, Canada, Australia
-
Ascendis Pharma A/SActive, not recruitingAchondroplasiaUnited States, Australia, Austria, Denmark, Germany, Ireland, New Zealand, Portugal
-
University of Alabama at BirminghamNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other collaboratorsCompletedOsteoporosisUnited States
-
Columbia UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)WithdrawnPrimary Hyperparathyroidism | Vitamin D Deficiency | Osteoporosis | Osteopenia | HypercalcemiaUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedBreast Cancer | OsteoporosisUnited States
-
Arrowhead PharmaceuticalsCompletedHypertriglyceridemia | Familial ChylomicronemiaAustralia, Canada, New Zealand
-
Eli Lilly and CompanyCompletedOsteoporosis, PostmenopausalUnited States, Canada
-
Arrow TherapeuticsDDS, Dundee; David Mutimer, Birmingham; Ed Gane, ACS New ZealandTerminatedChronic Hepatitis CNew Zealand, United Kingdom
-
Herbert Irving Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedBreast Cancer | OsteoporosisUnited States
-
Eli Lilly and CompanyCompleted
-
Eli Lilly and CompanyCompletedType 2 DiabetesIndia, Mexico, New Zealand, South Africa
-
Columbia UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedChronic Kidney Disease | Secondary Hyperparathyroidism | End Stage Kidney Disease | Chronic Kidney Disease Mineral and Bone Disorder | Renal OsteodystrophyUnited States
-
Alvotech Swiss AGCompletedHealthy Male SubjectsSouth Africa, Australia, New Zealand
-
Orient Pharma Co., Ltd.CompletedPrimary Hypercholesterolemia | Mixed DyslipidemiasTaiwan, Australia, New Zealand
-
Intellia TherapeuticsActive, not recruitingTransthyretin-Related (ATTR) Familial Amyloid Cardiomyopathy | Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy | Wild-Type Transthyretin Cardiac AmyloidosisFrance, United Kingdom, New Zealand, Sweden
-
St Vincent's Hospital, SydneyMerck Sharp & Dohme LLC; The Alfred; Holdsworth House Medical PracticeCompletedHIV Infections | HIV | Osteoporosis | OsteopeniaAustralia
-
NovartisNovartis PharmaceuticalsCompletedHepatitis BHong Kong, Singapore, New Zealand
-
Zealand University HospitalUniversity of Copenhagen; Pharma Nord; Psychiatric Research Unit, Region Zealand...CompletedDepression | Acute Coronary SyndromeDenmark
-
PfizerCompletedMenopause | OsteoporosisUnited States, Colombia, Australia, Hungary, Poland, Finland, Argentina, Chile, Denmark, Mexico, New Zealand, Norway
-
University of SouthamptonNational University Hospital, Singapore; Singapore Institute for Clinical Sciences and other collaboratorsEnrolling by invitationNeurobehavioral Manifestations | Allergy | Microbial Colonization | Growth Disorders | Atopic Dermatitis | Obesity, Childhood | Metabolic Disturbance | Cognition | Lifestyle | Breastfeeding | Nutrition, Healthy | AtopySingapore, United Kingdom, New Zealand
-
Novartis PharmaceuticalsCompleted
-
AlexionAchillion, a wholly owned subsidiary of AlexionCompletedParoxysmal Nocturnal HemoglobinuriaNew Zealand, Korea, Republic of, Italy
-
NovartisCompletedOsteoporosisUnited States, Belgium, Germany, Spain
-
Tarsa Therapeutics, Inc.CompletedOsteoporosis, PostmenopausalUnited States, United Kingdom, Bulgaria, Hungary, Poland, South Africa
-
Gilead SciencesCompletedChronic Hepatitis BUnited States, New Zealand
-
Eli Lilly and CompanyCompleted
-
Hoffmann-La RocheCompletedHepatitis C, ChronicNew Zealand, Poland, France
-
Hoffmann-La RocheCompletedHepatitis C, ChronicNew Zealand, Australia
-
James J. Peters Veterans Affairs Medical CenterKessler Institute for RehabilitationActive, not recruitingOsteoporosis | Spinal Cord InjuriesUnited States
-
W.L.Gore & AssociatesCompletedPeripheral Arterial Disease | Common Iliac Artery Occlusive Disease | External Iliac Artery Occlusive DiseaseNew Zealand
-
Mylan Inc.Theravance BiopharmaCompleted
-
Hoffmann-La RocheCompletedHepatitis B, ChronicNew Zealand
-
Ardea Biosciences, Inc.Completed
-
Shockwave Medical, Inc.Completed
-
Hoffmann-La RocheCompletedPost Menopausal OsteoporosisUnited States, Puerto Rico
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI)CompletedProstate Cancer | OsteoporosisUnited States
-
National Institute of Allergy and Infectious Diseases...Eunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedHIV Infections | Dyslipidemia | Osteoporosis | Osteopenia | Lipodystrophy | HIV-Associated Lipodystrophy Syndrome | HIV Lipodystrophy SyndromeUnited States, Puerto Rico
-
Novartis PharmaceuticalsCompletedBreast Cancer | Bone LossEgypt, Taiwan, Hong Kong, Thailand, Argentina, Germany, United Kingdom, Colombia, Belgium, Spain, Philippines, Italy, Brazil, China, Finland, Chile, Guatemala, Netherlands, New Zealand, Switzerland, Portugal, Venezuela, Australia, Czech... and more
-
Mylan Inc.Theravance BiopharmaCompletedChronic Obstructive Pulmonary Disease, COPDNew Zealand
-
EndologixCompletedPeripheral Arterial DiseaseNew Zealand
-
Avinger, Inc.WithdrawnPeripheral Arterial DiseaseNew Zealand
-
Anne Birgitte RabenUniversity of Nottingham; University of Helsinki; Wageningen University; University... and other collaboratorsCompletedObesity | Pre-diabetesSpain, Denmark, Australia, Bulgaria, Finland, Netherlands, New Zealand, United Kingdom
-
Hoffmann-La RocheCompletedEnd Stage Renal DiseaseNew Zealand